Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

What does the report of the USMHRP Phase III study in Thailand mean for HIV and for vaccine developers?

Graham BS.

Clin Exp Immunol. 2009 Dec;158(3):257-9. doi: 10.1111/j.1365-2249.2009.04055.x. No abstract available.

2.

Therapeutic vaccine trails in Thailand.

Churdboonchart V.

J HIV Ther. 2004 Sep;9(3):57-9. Review.

PMID:
15534562
3.

The HIV vaccine pipeline, from preclinical to phase III.

Schultz AM, Bradac JA.

AIDS. 2001;15 Suppl 5:S147-58. Review. No abstract available.

PMID:
11816163
4.

HIV/AIDS preventive vaccine 'prime-boost' phase III trial: foundations and initial lessons learned from Thailand.

Rerks-Ngarm S, Brown AE, Khamboonruang C, Thongcharoen P, Kunasol P.

AIDS. 2006 Jul 13;20(11):1471-9. Review. No abstract available.

PMID:
16847401
5.

Phase III HIV vaccine trial in Thailand: a step toward a protective vaccine for HIV.

Vaccari M, Poonam P, Franchini G.

Expert Rev Vaccines. 2010 Sep;9(9):997-1005. doi: 10.1586/erv.10.104. Review.

PMID:
20822342
6.

HIV vaccine research in Thailand: lessons learned.

Pitisuttithum P.

Expert Rev Vaccines. 2008 Apr;7(3):311-7. doi: 10.1586/14760584.7.3.311. Review.

PMID:
18393601
7.

HIV vaccine trials in Africa.

Sandström E, Birx D.

AIDS. 2002;16 Suppl 4:S89-95. Review. No abstract available.

PMID:
12699005
8.

Past, present and future of HIV vaccine trials in developing countries.

Esparza J, Osmanov S, Pattou-Markovic C, Touré C, Chang ML, Nixon S.

Vaccine. 2002 May 6;20(15):1897-8. Review.

PMID:
11983240
9.

HIV vaccine trial results are an important step forward in developing an effective vaccine, say WHO and UNAIDS.

Rassool GH.

J Adv Nurs. 2003 Jul;43(2):116. Review. No abstract available.

PMID:
12886893
10.

Building and testing an effective HIV vaccine.

Kahn J.

West J Med. 1999 Nov-Dec;171(5-6):363-5. Review. No abstract available.

12.

HIV-1 prophylactic vaccine trials in Thailand.

Pitisuttithum P.

Curr HIV Res. 2005 Jan;3(1):17-30. Review.

PMID:
15638720
13.

[Anti-HIV vaccines: state of the art and prospects].

Bektimirov TA.

Vopr Virusol. 2002 May-Jun;47(3):4-6. Review. Russian.

PMID:
12173435
14.

[The quest for an HIV vaccine].

Girard MP.

Bull Acad Natl Med. 2005 May;189(5):831-44; discussion 844. Review. French.

PMID:
16433455
15.
16.

ALVAC-HIV vaccines: clinical trial experience focusing on progress in vaccine development.

Marovich MA.

Expert Rev Vaccines. 2004 Aug;3(4 Suppl):S99-104. Review.

PMID:
15285709
17.

Social and behavioral issues in phase III HIV preventive vaccine trials.

Grinstead OA.

AIDS. 1995;9 Suppl A:S245-50. Review. No abstract available.

PMID:
8819592
18.

Poxvirus vector-based HIV vaccines.

Pantaleo G, Esteban M, Jacobs B, Tartaglia J.

Curr Opin HIV AIDS. 2010 Sep;5(5):391-6. doi: 10.1097/COH.0b013e32833d1e87. Review.

PMID:
20978379
19.

Challenges to conducting HIV preventative vaccine trials with adolescents.

McClure CA, Gray G, Rybczyk GK, Wright PF.

J Acquir Immune Defic Syndr. 2004 Jun 1;36(2):726-33. Review.

PMID:
15167292
20.

Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review.

Girard MP, Osmanov S, Assossou OM, Kieny MP.

Vaccine. 2011 Aug 26;29(37):6191-218. doi: 10.1016/j.vaccine.2011.06.085. Epub 2011 Jun 28. Review.

PMID:
21718747
Items per page

Supplemental Content

Write to the Help Desk